Stephen Rocamboli

Stephen Rocamboli

Director/Board Member chez ESPERION THERAPEUTICS, INC.

Fortune : 44 237 $ au 31/03/2024

52 ans
Health Technology
Finance
Commercial Services

Profil

Stephen Charles Rocamboli was the founder of Pear Tree Pharmaceuticals, Inc. (founded in 2008) where he held the title of President & Secretary from 2008 to 2018.
He is currently working as an Independent Director at Esperion Therapeutics, Inc., a Director at Cortice Biosciences, Inc., an Independent Director at TFF Pharmaceuticals, Inc. (since 2018), and a Director at Androvia Life Sciences.
In his former positions, he served as Chairman & Chief Executive Officer at Perla Therapeutics, Inc., Non-Executive Chairman & Secretary at VioQuest Pharmaceuticals, Inc. (from 2003 to 2009), Senior Managing Director & General Counsel at Paramount BioCapital, Inc. (from 1999 to 2007), and held various director roles at Cutanea Life Sciences, Inc., Foresight Biotherapeutics, Inc., Chitina Sciences, Inc., and Cordova Sciences, Inc. He also worked as Special Counsel at Wyrick Robbins Yates & Ponton LLP (from 2014 to 2015), Partner at Orion Biomedical Fund LP (from 1999 to 2007), and Deputy General Counsel at Paramount BioSciences LLC (from 1999 to 2004).
Additionally, he served as Secretary & Chief Business Officer at Candel Therapeutics, Inc. (from 2015 to 2020) and as General Partner at Integrin Partners LLC (from 2010 to 2015).
He was also a Partner at Beijing International Group LLC (from 2010 to 2012).
Mr. Rocamboli obtained an undergraduate degree from State University of New York at Albany and a graduate degree from Fordham University School of Law.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
15/06/2023 13 261 ( 0,01% ) 35 539 $ 31/03/2024
18/04/2024 1 440 ( 0,06% ) 8 698 $ 31/03/2024

Postes actifs de Stephen Rocamboli

SociétésPosteDébut
TFF PHARMACEUTICALS, INC. Director/Board Member 01/12/2018
ESPERION THERAPEUTICS, INC. Director/Board Member 28/04/2022
Androvia Life Sciences Director/Board Member -
Director/Board Member -
Tous les postes actifs de Stephen Rocamboli

Anciens postes connus de Stephen Rocamboli

SociétésPosteFin
CANDEL THERAPEUTICS, INC. General Counsel 01/05/2020
Founder 01/05/2018
Corporate Officer/Principal 01/04/2015
Director/Board Member 01/01/2015
General Counsel 01/01/2015
Voir l'expérience en détail de Stephen Rocamboli

Formation de Stephen Rocamboli

State University of New York at Albany Undergraduate Degree
Fordham University School of Law Graduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Stephen Rocamboli

Relations

75

Relations au 1er degré

20

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées4
VIOQUEST PHARMACEUTICALS, INC.

Health Technology

ESPERION THERAPEUTICS, INC.

Health Technology

CANDEL THERAPEUTICS, INC.

Health Technology

TFF PHARMACEUTICALS, INC.

Health Technology

Entreprise privées14

Finance

Finance

Finance

Health Technology

Health Technology

Health Technology

Commercial Services

Orion Biomedical Fund LP

Finance

Health Technology

Commercial Services

Beijing International Group LLC

Androvia Life Sciences

Perla Therapeutics, Inc.

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Stephen Rocamboli